Skip to main content

Table 1 Clinical and demographic data of AKI cases and non-AKI controls of post-cardiac surgery patients

From: Acute kidney injury prediction in cardiac surgery patients by a urinary peptide pattern: a case-control validation study

Parameter

AKI

Non-AKI

p

Patients/samples (n/n)

59/59

51/51

 

Age (years)

65 (45–77)

60 (24–77)

0.03

Gender (female/male)

13/46

16/35

0.29

EuroSCORE II** (points)

6.82 (0.86–28.34)

5.99 (0.67–21.93)

0.89

Body mass index

30.7 (19.9–47.3)

30.8 (17.3–41.4)

0.86

S-creatinine at baseline (mg/dL)

1.1 (0.6–1.9)

0.9 (0.6–1.3)

<0.001

Estimated glomerular filtration rate at baseline (mL/h/1.73 m2)‡,†

73 (37–110)

92 (56–132)

<0.001

Diabetes (%)

29

18

0.19

OP time (min)

214 (105–390)

211 (109–651)

0.6

Time of cardiopulmonary bypass (min)

109 (48–243)

103 (34–177)

0.81

Clamping time (min)

66 (17–184)

67 (26–125)

0.77

Endpoints:

   

 NOMI (%)ǁ

29

2

<0.001

 Death (%)ǁ

17

0

0.002

AKI staging (n):

   

 0

0

51

 

 1

25

0

 

 2

14

0

 

 3

20 (15 w/ hemodialysis)

0

 
  1. AKI acute kidney injury, NOMI nonocclusive mesenteric ischemia,
  2. **Thoracic Surgeons Risk Score to predict mortality after thoracic surgery, for calculation see: http://www.euroscore.org/
  3. According to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)
  4. Given as mean (range)
  5. ǁ7 % of AKI patients with composite endpoint